Healthcare provider profile · identity verified

Mikhail Shulman, FNP-C

Nurse Practitioner · SKOKIE, IL · NPI 1396309548

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	611	83
Amlodipine Besylate	Amlodipine Besylate	589	68
Memantine Hcl	Memantine Hcl	413	60
Furosemide	Furosemide	406	69
Donepezil Hcl	Donepezil Hcl	398	51
Quetiapine Fumarate	Quetiapine Fumarate	380	43
Losartan Potassium	Losartan Potassium	354	47
Levothyroxine Sodium	Levothyroxine Sodium	348	51
Sertraline Hcl	Sertraline Hcl	345	57
Metoprolol Succinate	Metoprolol Succinate	321	41
Eliquis	Apixaban	299	44
Metoprolol Tartrate	Metoprolol Tartrate	240	32
Pantoprazole Sodium	Pantoprazole Sodium	214	34
Potassium Chloride	Potassium Chloride	210	28
Omeprazole	Omeprazole	208	33
Tamsulosin Hcl	Tamsulosin Hcl	184	31
Escitalopram Oxalate	Escitalopram Oxalate	177	33
Lisinopril	Lisinopril	170	30
Gabapentin	Gabapentin	165	31
Trazodone Hcl	Trazodone Hcl	163	33
Mirtazapine	Mirtazapine	156	30
Hydrochlorothiazide	Hydrochlorothiazide	124	11
Spironolactone	Spironolactone	123	29
Famotidine	Famotidine	119	20
Rosuvastatin Calcium	Rosuvastatin Calcium	117	18
Risperidone	Risperidone	108	17
Carvedilol	Carvedilol	101	22
Divalproex Sodium Er	Divalproex Sodium	100	19
Clopidogrel	Clopidogrel Bisulfate	88	suppressed
Olanzapine	Olanzapine	87	19
Divalproex Sodium	Divalproex Sodium	76	13
Citalopram Hbr	Citalopram Hydrobromide	75	12
Finasteride	Finasteride	75	14
Oxybutynin Chloride Er	Oxybutynin Chloride	73	suppressed
Prednisone	Prednisone	69	25
Lorazepam	Lorazepam	65	20
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	62	suppressed
Duloxetine Hcl	Duloxetine Hcl	62	suppressed
Montelukast Sodium	Montelukast Sodium	62	suppressed
Alprazolam	Alprazolam	59	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	16
Pravastatin Sodium	Pravastatin Sodium	59	suppressed
Metformin Hcl Er	Metformin Hcl	57	suppressed
Levetiracetam	Levetiracetam	56	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	32
Warfarin Sodium	Warfarin Sodium	53	suppressed
Metformin Hcl	Metformin Hcl	52	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	51	11
Chlorthalidone	Chlorthalidone	51	suppressed
Jardiance	Empagliflozin	51	suppressed
Simvastatin	Simvastatin	50	suppressed
Bumetanide	Bumetanide	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Buspirone Hcl	Buspirone Hcl	46	suppressed
Allopurinol	Allopurinol	45	11
Latanoprost	Latanoprost	45	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	23
Hydralazine Hcl	Hydralazine Hcl	41	11
Tramadol Hcl	Tramadol Hcl	41	26
Aripiprazole	Aripiprazole	40	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Nifedipine Er	Nifedipine	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	27
Myrbetriq	Mirabegron	35	suppressed
Glimepiride	Glimepiride	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	31	suppressed
Ramipril	Ramipril	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Methenamine Hippurate	Methenamine Hippurate	30	suppressed
Nystop	Nystatin	30	15
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Atenolol	Atenolol	27	suppressed
Bethanechol Chloride	Bethanechol Chloride	27	suppressed
Enulose	Lactulose	27	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	24	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	21
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Torsemide	Torsemide	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Multaq	Dronedarone Hcl	22	suppressed
Nystatin	Nystatin	22	17
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Amantadine	Amantadine Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Loperamide	Loperamide Hcl	18	14
Timolol Maleate	Timolol Maleate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Baclofen	Baclofen	17	suppressed
Lorazepam Intensol	Lorazepam	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	13
Rivastigmine	Rivastigmine Tartrate	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	11
Entacapone	Entacapone	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Levofloxacin	Levofloxacin	15	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Meclizine Hcl	Meclizine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Prednisolone Acetate	Prednisolone Acetate	14	suppressed
Budesonide Dr	Budesonide	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Letrozole	Letrozole	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Econazole Nitrate	Econazole Nitrate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Temazepam	Temazepam	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error